Free Trial

Genus (LON:GNS) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?

Genus logo with Medical background

Key Points

  • Genus plc's stock price exceeded its two hundred-day moving average, reaching a high of GBX 2,495 ($33.72) and last traded at GBX 2,440 ($32.98).
  • Deutsche Bank and Shore Capital have upgraded Genus with a "buy" rating, increasing the target price to GBX 2,900.
  • The company's recent earnings report indicated GBX 81.80 earnings per share (EPS) for the quarter, with analysts predicting an EPS of approximately 70.96 for the current fiscal year.
  • Five stocks we like better than Genus.

Genus plc (LON:GNS - Get Free Report) passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 2,143.64 ($28.97) and traded as high as GBX 2,495 ($33.72). Genus shares last traded at GBX 2,440 ($32.98), with a volume of 70,610 shares trading hands.

Analyst Upgrades and Downgrades

GNS has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft upped their target price on Genus from GBX 2,550 to GBX 2,900 and gave the company a "buy" rating in a research note on Monday, September 15th. Shore Capital restated a "buy" rating and issued a GBX 2,900 target price on shares of Genus in a research note on Thursday, September 4th. Two investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of GBX 2,900.

Get Our Latest Stock Analysis on Genus

Genus Stock Up 0.4%

The company has a debt-to-equity ratio of 53.12, a current ratio of 1.80 and a quick ratio of 1.08. The firm has a 50 day simple moving average of GBX 2,547.34 and a 200-day simple moving average of GBX 2,143.64. The stock has a market capitalization of £1.61 billion, a price-to-earnings ratio of -39,516.13, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37.

Genus (LON:GNS - Get Free Report) last released its quarterly earnings data on Thursday, September 4th. The company reported GBX 81.80 earnings per share (EPS) for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. On average, sell-side analysts forecast that Genus plc will post 70.9644323 EPS for the current fiscal year.

About Genus

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genus Right Now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report
Like this article? Share it with a colleague.